Neutrophil Gelatinase-Associated Lipocalin Protects Acinar Cells From Cerulein-Induced Damage During Acute Pancreatitis
Rakesh Bhatia, Sakthivel Muniyan, Christopher M Thompson, Sukhwinder Kaur, Maneesh Jain, Rakesh K Singh, Amaninder Dhaliwal, Jesse L Cox, Shizuo Akira, Shailender Singh, Surinder K Batra, Sushil Kumar, Rakesh Bhatia, Sakthivel Muniyan, Christopher M Thompson, Sukhwinder Kaur, Maneesh Jain, Rakesh K Singh, Amaninder Dhaliwal, Jesse L Cox, Shizuo Akira, Shailender Singh, Surinder K Batra, Sushil Kumar
Abstract
Objectives: Elevated neutrophil gelatinase-associated lipocalin (NGAL) is a promising marker for severe acute pancreatitis (SAP) and multiple organ failure, suggesting systemic and local contributions during pancreatitis. We investigated the role of NGAL locally on acinar cell biology.
Methods: Western blot, reverse transcriptase-polymerase chain reaction, and immunohistochemistry analysis were performed to analyze the levels of NGAL receptors, apoptotic and regeneration markers, and 4-hydroxynonenal (4HNE) levels, 3-[4,5-Dimethylthiazole-2-yl]-2, 5-diphenyltetrazolium bromide assay, and annexin V/propidium iodide staining were used to evaluate cell viability, and effect on endothelial cells was accessed by endothelial permeability assay.
Results: Cerulein treatment at 20 μM for 12 hours significantly reduced acinar cell viability by 40%, which was rescued by NGAL at 800 and 1600 ng/mL concentrations, observed during mild and SAP, respectively. Mechanistically, NGAL significantly reduced the levels of reactive oxygen species and 4HNE adduct formation in a 24p3R-dependent manner and upregulated the expression of acinar cell regeneration markers, like CDK-2, CDK-4, and C-myc. However, SAP levels of NGAL significantly increased endothelial permeability and downregulated the levels of ZO-1, and cerulein treatment in NGAL knockout mice showed increased levels of 4HNE adducts.
Conclusions: Neutrophil gelatinase-associated lipocalin rescues intracellular reactive oxygen species during pancreatitis and promotes survival and regeneration of acinar cells.
Conflict of interest statement
S.K.B. is a cofounder of Sanguine Diagnostics and Therapeutics Inc. The other authors declare no conflict of interest.
Figures
Source: PubMed